(Figures in the brackets refer to the same period the previous year)
During the third quarter of 2024, BioGaia will record…
BioGaias (NASDAQ: BIOG) financial report for the third quarter of 2024 will be published at approximately 8:00 AM CEST on…
The number of shares and votes in BioGaia AB (publ) increased in September due to the exercise of some warrants…
The number of shares and votes in BioGaia AB (publ) increased in August due to the exercise of some warrants…
The number of shares and votes in BioGaia AB (publ) increased in July due to the exercise of some warrants…
BioGaias (NASDAQ: BIOG) financial report for the second quarter of 2024 will be published at approximately 8:00 AM CEST on…
BioGaia AB, a Swedish world-leading probiotics company, is establishing its own distribution in Australia and New Zealand through two newly…
The Annual General Meeting of BioGaia AB (publ) on 7 May 2024 voted, among other things, to approve the following…
BioGaias (NASDAQ: BIOG) financial report for the first quarter of 2024 will be published at approximately 8:00 AM CEST on…
BioGaia AB (publ) will hold its Annual General Meeting at 4:00 p.m. on Tuesday, 7 May 2024, at Klara Konferens…
The BioGaia (NASDAQ: BIOG) Annual and Sustainability Report 2023, including Corporate Governance Report 2023, and the Remuneration Report 2023 in…
BioGaias (NASDAQ: BIOG) financial report for the fourth quarter of 2023 will be published at approximately 8:00 AM CET on…
Companies covered in this study are Probi AB, Abbott, Lonza, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd.,…
(Figures in the brackets refer to the same period the previous year)
During the third quarter of 2023, BioGaias sales have…
BioGaias (NASDAQ: BIOG) financial report for the third quarter of 2023 will be published at approximately 8:00 AM CEST on…
BioGaia announces that Theresa Agnew begins her role today, 25 September 2023, as the Chief Executive Officer of BioGaia.
As previously…
In a paper published in the journal Nature, a team of researchers from the University of Gothenburg and MetaboGen, a…
Today BioGaia´s board of directors has appointed Theresa P. Agnew as the new chief executive officer.
Theresa Agnew is a global…
SECOND QUARTER 2023
Figures in parentheses refer to the corresponding period last year, unless otherwise specified.
· Net sales amounted…
BioGaias (NASDAQ: BIOG) financial report for the second quarter of 2023 will be published at approximately 8:00 AM CEST on…
BioGaia has been awarded a gold medal recognizing its sustainability achievements by EcoVadis, one of the worlds most trusted providers…
Das Instrument BGLA SE0017769995 BIOGAIA AB B O.N. EQUITY wird ex Dividende/Zinsen…
The Annual General Meeting of BioGaia AB (publ) on 5 May 2023 voted, among other things, to approve the following…
FIRST QUARTER 2023
Figures in parentheses refer to the corresponding period last year, unless otherwise specified.
· Net sales amounted…
BioGaias (NASDAQ: BIOG) financial report for the first quarter of 2023 will be published at approximately 8:00 AM CEST on…
Prenatal Care is a probiotic food supplement that contains BioGaias patented bacteria strain L. reuteri DSM 17938 along with folic…
BioGaia AB (publ) will hold its Annual General Meeting at 4:00 p.m. on Friday, 5 May 2023, at Kapitel 8,…
For the first time in its over 30-year history, BioGaia is launching its own cosmetic probiotic product, Aldermis. Childrens skin,…
Isabelle Ducellier, Chief Executive Officer has today announced that she has decided to resign from the company and take on…
The BioGaia (NASDAQ: BIOG) Annual and Sustainability Report 2022, Remuneration Report 2022 and Corporate Governance Report 2022 in Swedish as…
DUBLIN, Feb. 13, 2023 /PRNewswire/ -- The "Probiotics Market, by Type, by Application, by Ingredient, and by Region - Size,…
FOURTH QUARTER 2022
· Net sales amounted to SEK 274.3 million (206.2), an increase of SEK 68.1 million, or…
BioGaias (NASDAQ: BIOG) financial report for the fourth quarter and full year of 2022 will be published at approximately 8:00…